EDITOR:
Fauli and colleagues [1] are to be congratulated for their investigation into aprotinin use at cardiac surgery and its effects on subclinically detected renal injury and dysfunction as estimated using beta-Nacetyl-beta-D glucosaminidase (NAG)/creatinine and ␣-1-microglobulin (␣-1-m)/creatinine ratios, respectively. In particular, a study period of up to 40 days postoperatively is helpful.
The authors show no significant effect of aprotinin administration on NAG/creatinine ratios, suggesting that subclinical tubular injury was not increased by this agent. However, they found a dose dependent increase in ␣-1-m/creatinine ratios suggesting aprotinin-mediated tubular dysfunction [1] . This interesting observation led to the conclusion that 'the use of high-dose aprotinin in older patients or in patients with preoperative renal dysfunction deserves more cautious consideration [1] . ' Our group has considerable experience in measurement of NAG/creatinine and ␣-1-m/creatinine ratios at cardiac surgery both with [2] and without [3] cardiopulmonary bypass (CPB). Unlike Fauli's study, which did not obtain a 48 h urinary sample, we have described, in the CPB patients, a transient second peak in urinary NAG at 48 h [2] which we call the 'lag in the NAG'. Interestingly, this delayed peak at 48 h is found in patients undergoing their surgery with CPB, but was less pronounced at off pump CAB surgery [3] , suggesting that this delayed 48 h peak in NAG is CPB specific. Moreover, in an investigation of the possible renoprotective effects of preoperatively administered methylprednisolone (MP) we found that MP significantly reduced the delayed peak in NAG/creatinine ratios at 48 h but not the early peak [4] . Had we not measured a 48 h sample we would have missed the renoprotective effect of MP, which had earlier been highlighted in the context of infra-renal ischaemia-reperfusion-mediated renal tubular injury [5] . Of particular relevance to Fauli's study, we found that MP increased urinary ␣-1-m/creatinine ratios (subclinical renal dysfunction) at cardiac surgery in the absence of any increases in urinary NAG (subclinical renal injury). We noted that the reduction in reabsorptive function which accompanies transient tubular dysfunction (as indicated by transiently increased urinary ␣-1-m/creatinine ratios) may be renally protective through diminishing tubular work and thus oxygen demand [4] . This argument similarly applies to Fauli's report of aprotinin-mediated temporary increases in tubular dysfunction (␣-1-m) in the absence of increased tubular injury (NAG). Moreover, since ␣-1-m has antiinflammatory effects [6] increased amounts in the filtrate may even be beneficial.
Clearly more studies are needed to determine if Fauli's interesting report of transient renal dysfunction induced by aprotinin, translates into a renal protective mechanism through temporarily reducing renal oxygen demand during the perioperative period, when oxygen delivery to the kidney is sometimes compromised.
Reply

EDITOR:
We appreciate the comments and interest shown by Dr McBride and his collaborators [1] regarding our study concerning kidney-specific proteins and aprotinin at high-and low-dose regimens during coronary artery bypass grafts with cardiopulmonary bypass. We agree with all of those aspects referred to by the authors and we will try to clarify certain aspects of their comments.
The designs of the two studies [1, 2] are different, with different recording times. Our results are not therefore directly comparable with those of McBride's results concerning the renal protection of aprotinin. We measured the variables at those particular times because aprotinin exhibits prolonged adherence of up 5-6 days to the epithelial cells of the proximal renal tubules [3] . We could not find a second peak in urinary beta-N-acetyl-beta-D glucosaminidase (NAG) at 48 h in the urine, instead, we observed a significant increase of NAG and alpha-1-microglobulin (␣-1-m) at 24 h, 72 h and on the 7th day into three groups, and recovery took place between the 7th and 40th days postoperatively. Perhaps there was an increase at 48 h related with our results as well as the 72 h increase of ␣-1-m in all groups studied (included placebo group).
In our opinion, the increase in NAG (reflecting cellular damage) could appear first and before renal dysfunction (shown by a increased urinary ␣-1-m) and perhaps in this way our result could be related to those of Dr McBride [1] . This could be a temporary dosedependant protective mechanism of aprotinin (reduction in reabsorptive function indicated by increased urinary ␣-1-m).
A. Fauli
